Andere Kunden interessierten sich auch für
![Generation of Long Acting Therapies Using Glycosylated Linkers]( "Generation of Long Acting Therapies Using Glycosylated Linkers")
Generation of Long Acting Therapies Using Glycosylated Linkers58,99 €![Formulation and Evaluation of Sustained Release Formulations]( "Formulation and Evaluation of Sustained Release Formulations")
Formulation and Evaluation of Sustained Release Formulations36,99 €![Rapid Paediatrics and Child Health]( "Rapid Paediatrics and Child Health")
Rapid Paediatrics and Child Health54,99 €![Rapid Intubation Sequence in the prehospital setting]( "Rapid Intubation Sequence in the prehospital setting")
Rapid Intubation Sequence in the prehospital setting29,99 €![Imported malaria: Evaluation of 2 rapid diagnostic tests]( "Imported malaria: Evaluation of 2 rapid diagnostic tests")
Imported malaria: Evaluation of 2 rapid diagnostic tests29,99 €![Design of an educational intervention on prostate cancer.]( "Design of an educational intervention on prostate cancer.")
Design of an educational intervention on prostate cancer.29,99 €![Epidemiology of oral cancer. Precancerous lesions and conditions, primary prevention and surgical management]( "Epidemiology of oral cancer. Precancerous lesions and conditions, primary prevention and surgical management")
Epidemiology of oral cancer. Precancerous lesions and conditions, primary prevention and surgical management47,95 €
A rational and transparent method, System of Objectified Judgement Analysis (SOJA), for drug selection is described for selection of rapid acting fentanyl formulations for breakthrough pain in cancer-related pain. The relevant selection criteria for a group of drugs are defined and judged by a panel of experts. The more important that a selection criterion is considered, the higher the relative weight that is given to that criterion. The ideal properties for each selection criterion are determined and each drug is scored as a percentage of the relative weight for all selection criteria. Selection criteria (relative weight) were: number of available strengths (60), variability in rate of absorption (50), interactions (50), clinical efficacy (350), side-effects (150), ease of administration (140) and documentation (200). The sublingual fentanyl orally disintegrating tablet (Abstral) showed the highest overall score, followed by the nasal sprays (Instanyl and PecFent). These are themost attractive formulations from a formulary perspective.